QuidelOrtho
QDEL
$39.75
Share price
0.15%
Change (1 day)
-55.61%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
Market capitalization of QuidelOrtho (QDEL)
Market cap: $2.65 Billion
As of April 2024 QuidelOrtho has a market cap of $2.65 Billion. This makes QuidelOrtho the world's 3653th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of QuidelOrtho from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.65 B | -46.02% |
| 2023 | $4.92 B | -12.96% |
| 2022 | $5.65 B | 0.55% |
| 2021 | $5.62 B | -25.54% |
| 2020 | $7.55 B | 140.58% |
| 2019 | $3.14 B | 63.37% |
| 2018 | $1.92 B | 30.47% |
| 2017 | $1.47 B | 110.77% |
| 2016 | $0.69 B | -1.02% |
| 2015 | $0.70 B | -29.06% |
| 2014 | $0.99 B | -5.39% |
| 2013 | $1.05 B | 68.52% |
| 2012 | $0.62 B | 24.15% |
| 2011 | $0.50 B | 22.09% |
| 2010 | $0.41 B | 3.01% |
| 2009 | $0.39 B | -5.98% |
| 2008 | $0.42 B | -33.2% |
| 2007 | $0.63 B | 39.44% |
| 2006 | $0.45 B | 25.19% |
| 2005 | $0.36 B | 125.48% |
| 2004 | $0.16 B | -50.6% |
| 2003 | $0.32 B | 226.77% |
| 2002 | $0.10 B | -54.56% |
| 2001 | $0.22 B |
End of Day market cap according to different sources
On Apr 25th, 2024 the market cap of QuidelOrtho was reported to be:
$2.65 Billion
$2.65 Billion
$2.65 Billion
$2.65 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $218.96 B | 8,136.61% | 🇺🇸 USA |
 Becton Dickinson BDX | $67.17 B | 2,426.78% | 🇺🇸 USA |
 Danaher DHR | $183.44 B | 6,800.54% | 🇺🇸 USA |
 PerkinElmer
PKI | $14.45 B | 443.77% | 🇺🇸 USA |
 OraSure Technologies OSUR | $0.40 B | -84.63% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $1.48 B | -44.00% | 🇺🇸 USA |